SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply as its highly positive Phase 2 axSpA clinical data, robust financial updates, and institutional accumulation fuel intense investor anticipation, positioning sonelokimab as a potential best-in-class drug and igniting buyout speculation ahead of its upcoming Investor Day.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN symbol is trending due to significant community discussion surrounding a new 'Mullen Army' crypto token that leverages the controversial Mullen Automotive name; many investors are expressing strong skepticism, citing the stock's history of reverse splits and dilution, while some proponents claim the token offers utility and a revolutionary movement.

We're a deflationary token that builds utility around our BTC and ETH reserves.  Our main goal is to onboard newbies in the friendliest and safest way, that's why we launched our NFT book (definitely for dummies) on five chains one year ago.  Our new swap generates revenue that combined with our taxes allow us to grow at a slow but steady pace; We're completely sustainable because our monthly expenses are really low.

PiggyCoinBSC

PiggyCoinBSC ($PIGGYC) is trending as its community actively engages in X spaces, highlighting its unique tokenomics that include $BTC and $ETH strategic reserves, and the utility of its new multi-chain swap platform, Swappy. Despite strong bullish sentiment from supporters, some community members are voicing concerns and labeling it a scam.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending driven by institutional interest following a Grayscale S-1 filing for a NEAR Trust, alongside its expanding utility in cross-chain liquidity via 'NEAR Intents' and significant advancements in AI integration. Despite recent price volatility that has divided community sentiment, many are accumulating, banking on its reduced token inflation and strategic position in the AI-crypto ecosystem.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is surging following a substantial earnings beat and optimistic outlook for record revenues in 2026, fueled by its patented high-density power solutions crucial for AI data centers and successful IP licensing; however, some technical traders are eyeing consolidation after the rapid ascent.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending amid a strategic pivot to AI/HPC cloud services and data center expansion, supported by solid Q4 revenue and a large capital raise; however, the community is actively debating the impact of this substantial dilution and the sale of all its Bitcoin holdings, leading to significant stock volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as a Supreme Court decision to strike down prior tariffs prompted an immediate announcement of new, 15% global tariffs. This has ignited community debate over potential inflationary pressures and consumer financial impacts, linking the company to broader economic policy discussions.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF (XOP) is heavily discussed as escalating geopolitical tensions, including potential disruptions in the Strait of Hormuz and new US sanctions on major Russian oil entities, fuel concerns about global energy supply. Community sentiment is sharply divided, with some anticipating a significant oil price surge from tight inventories while others contend prices are being deliberately suppressed despite strong underlying demand.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending amid active community discussion regarding its "move-to-earn" utility and speculation on its future valuation. Investors are divided between those accumulating with long-term hopes for a rebound and those cautioning against its volatile nature, often noting its association with NEAR Protocol.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is actively trending following FDA approval for Bysanti, an antipsychotic granted New Chemical Entity (NCE) status with patent protection until 2044. The community views this unexpected long-term exclusivity as a transformative event, anticipating significant analyst re-ratings and potential multi-billion dollar buyout offers from major pharmaceutical companies seeking to address their own patent cliffs, alongside excitement for Vanda's broader pipeline, including a GLP-1 related nausea drug.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanguard Group Inc. Decreases Stock Holdings in Neurocrine Biosciences, Inc. $NBIX

Vanguard Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 1.0% during the third quarter, according to its most recent 13F filing with the SEC. The...

Neurocrine Biosciences, Inc. $NBIX Position Trimmed by Persistent Asset Partners Ltd

Persistent Asset Partners Ltd decreased its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 59.8% in the third quarter, according to its most recent filing with the Securities...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Fiera Capital Corp

Fiera Capital Corp cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the Securities and...

Aberdeen Group plc Reduces Stock Holdings in Neurocrine Biosciences, Inc. $NBIX

Aberdeen Group plc lowered its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 23.9% during the 3rd quarter, according to the company in its most recent Form 13F filing...

Neurocrine Biosciences (NASDAQ:NBIX) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research lowered Neurocrine Biosciences from a "hold" rating to a "strong sell" rating in a research report on Tuesday...

Skandinaviska Enskilda Banken AB publ Reduces Holdings in Neurocrine Biosciences, Inc. $NBIX

Skandinaviska Enskilda Banken AB publ reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 15.6% in the 3rd quarter, according to its most recent filing with the SEC...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) have been given an average rating of "Moderate Buy" by the twenty-one ratings firms that are currently covering the firm...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Eagle Health Investments LP

Eagle Health Investments LP cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 25.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

New Strong Sell Stocks for February 18th

COIN, NBIX and UPST have been added to the Zacks Rank #5 (Strong Sell) List on February 18th, 2026.

JPMorgan Chase & Co. Has $664.02 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX

JPMorgan Chase & Co. increased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 11.0% in the 3rd quarter, according to its most recent disclosure with the...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.